Following in the footsteps of other pharmaceutical companies, Bristol Myers Squibb and Pfizer are offering Eliquis for cash-paying patients at a discount of 40% off the list price.

LLY's explosive growth from Mounjaro and Zepbound outpaces MRK's Keytruda-led gains, despite valuation concerns.

When I was assigned to write my first story about the blockbuster weight loss drug Ozempic in 2023, I groaned. Yes, weight loss drugs always generate feverish interest, but historically, they’ve both ...

Testosterone plays a critical role in male sexual functioning but can also impact bone mass, fat distribution, muscle mass, ...

A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring ...

Kym Whitely is not opposed to bringing her Young & Hungry cast together again. Though the show, which ran from 2014 to 2018, ...

Roughly 16 million American adults are taking GLP-1 medications. They are a major breakthrough for people to shed pounds and ...